Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

IFN-λ decreases miR-122 transcription in HCV cells. by Fatma Aboulnasr (736868)

Melatonin and hypoxia/reoxygenation decrease the mitochondrial content in BeWo cells. by Lucas Sagrillo-Fagundes (6194843)

TIPE2 deficiency increases NO production but decreases urea production in macropahges. by Yunwei Lou (560831)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Decreased cell motility and invasion <i>in vitro</i> by Met knockdown. by Kristen S. Hill (151089)

“…Values represent the fold change in the number of cells/field and are reported as the mean +/− SEM (***p<0.001; ANOVA, n = 3). Live cell imaging of ASPC-1 MetKD cells plated on collagen I-coated glass bottom cell culture dishes show decreased cell migration in response to 100 ng/mL HGF (D). …”

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”

PKCδ inhibition decreases CXCL4-induced cord dissociation. by Joshua Jamison (470566)

Anti-angiogenic effect of CNT decreased in autophagy- or apoptosis-inhibited cells. by Seung Ya Yang (541930)

Beneficial effects of a gait used while wearing a kimono to decrease the knee adduction moment in healthy adults by Susumu Ota (4167205)

“…The 1^st and 2^nd peak KAMs were significantly decreased during Nanba walking (0.40±0.09 and 0.37±0.13 Nm/kg) compared with normal walking (0.45±0.09 and 0.45±0.13 Nm/kg; P = 0.002, P<0.001, respectively). …”

IFNγ decreases cell proliferation of NPCs via p21. by Johanna Mäkelä (223358)

“…<p>NPCs were treated with 100 ng/ml IFNγ for 2 days. *p<0.05 and ***p<0.001 comparing IFNγ treated vs. controls. …”

TSA treatment significantly decreases total cholesterol content in neuroblastoma cells. by Maria João Nunes (160499)

OPN-deficiency decreases inflammation, oxidative stress and fibrosis in adipose tissue. by Andoni Lancha (335824)

PGE₂ decreases <i>Sost</i> expression. by Damian C. Genetos (325684)

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

Melatonin decreases the viability of BeWo cells under hypoxia/reoxygenation. by Lucas Sagrillo-Fagundes (6194843)

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”